China is grappling with an outbreak of the human metapneumovirus (HMPV), five years after the Covid-19 pandemic began. Reports from social media and through the sources of Leaders team reveal the virus is spreading rapidly, with claims of overcrowded hospitals and crematoriums, raising alarm across the country.
Videos circulating online depict overwhelmed medical facilities, with some users highlighting the simultaneous spread of various respiratory viruses, including Influenza A, HMPV, Mycoplasma pneumoniae, and Covid-19. While unconfirmed reports suggest a state of emergency has been declared, Chinese health authorities are closely monitoring the situation.
HMPV, a virus that mimics flu-like and Covid-19 symptoms, is a growing concern. The X account “SARS-CoV-2 (Covid-19)” reported:
“China is experiencing a surge in multiple viruses, including Influenza A, HMPV, Mycoplasma pneumoniae, and Covid-19, overwhelming hospitals and crematoriums. Children’s hospitals are particularly burdened by rising cases of pneumonia and ‘white lung’ conditions.”
Strengthening Surveillance Systems
According to the reports of Leaders team, to combat the outbreak, China’s disease control authority has initiated a pilot monitoring system for pneumonia of unknown origins. This system aims to improve early detection and response to emerging pathogens, addressing the shortcomings faced during the initial Covid-19 outbreak. Laboratory reporting procedures and case verification protocols are being established to enhance the country’s preparedness, according to state broadcaster CCTV.
Between December 16 and 22, acute respiratory cases rose sharply, with health officials predicting a further increase during winter and spring. Senior health official Kan Biao stated that while overall cases are expected to be fewer than last year, respiratory infections remain a significant concern.
Public Health Advisory
HMPV infections, especially among children under 14 in northern provinces, are on the rise. Experts caution against the indiscriminate use of antiviral drugs, noting that no vaccine exists for HMPV. The virus typically causes cold-like symptoms, and treatment should be focused on managing the illness appropriately.
